We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About ADARx Pharmaceuticals Stock

Invest in or calculate the value of your shares in ADARx Pharmaceuticals or other pre-IPO companies through EquityZen's platform.

Get Started

ADARx Pharmaceuticals Stock (ADPH)

ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts.

About ADARx Pharmaceuticals Stock

Founded

2019

Headquarters

San Diego, CA, US

Industries

Software, Artificial Intelligence, Data and Analytics

ADARx Pharmaceuticals is a genetic medicine company focusing on the base editing of mRNA transcripts. It discovers and develops innovative therapeutics that can utilize a family of endogenous enzymes called adenosine deaminase acting on RNA (ADAR) to precisely target and correct single point mutations on an mRNA, thus the production of desired and functional protein is restored. The company was founded in 2019 and is headquartered in San Diego, California.

ADARx Pharmaceuticals Press Mentions

Stay in the know about the latest news on ADARx Pharmaceuticals

ADARx Pharmaceuticals Management

Leadership team at ADARx Pharmaceuticals

Founder, President & CEO

Zhen Li

Chief Medical Officer

Hubert Chen

Locked Features

Join now and verify your accreditation status to gain access to:

  • ADARx Pharmaceuticals current valuation
  • ADARx Pharmaceuticals stock price
  • Available deals in ADARx Pharmaceuticals and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

Trading ADARx Pharmaceuticals Stock

How to invest in ADARx Pharmaceuticals stock?

Accredited investors can buy pre-IPO stock in companies like ADARx Pharmaceuticals through EquityZen funds. These investments are made available by existing ADARx Pharmaceuticals shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell ADARx Pharmaceuticals stock?

Shareholders can sell their ADARx Pharmaceuticals stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."